Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol
- PMID: 36006961
- PMCID: PMC9409582
- DOI: 10.1371/journal.pone.0267617
Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol
Abstract
Introduction: The human papillomavirus (HPV) is sexually transmitted and infects approximately 75% of sexually active people early in their sexual life. Persistent infection with oncogenic HPV types can lead to malignant conditions such as cervical cancer. In 2006, the World Health Organisation approved the use of an efficacious HPV vaccine for girls aged 9 to 14 to prevent HPV-related conditions. Despite the HPV vaccine being available for about 15 years, dose completion remains as low as 20% in sub-Saharan African (SSA) countries implementing the vaccination program compared to 77% in Australia and New Zealand. A fraught of barriers to implementation exist which prevent adequate coverage. Achieving success for HPV vaccination in real-world settings requires strategies to overcome implementation bottlenecks. Therefore, a better understanding and mapping of the implementation strategies used in sub-Saharan Africa to increase HPV vaccination uptake is critical. This review aims to identify implementation strategies to increase HPV vaccination uptake for adolescent girls in sub-Saharan Africa and provide a basis for policy and future research, including systematic reviews to evaluate effective strategies as we accelerate the elimination of cervical cancer.
Materials and methods: This scoping review will consider studies pertaining to implementation strategies to increase HPV vaccination uptake for adolescent girls in sub-Saharan Africa. Studies targeted at different stakeholders to increase adolescent vaccine uptake will be included. Studies using interventions not fitting the definition of implementation strategies as defined by the refined compilation of implementation strategies from the Expert Recommendations for Implementing Change project will be excluded. MEDLINE (via PubMed), Embase, CINAHL (via EBSCO), Scopus and Google Scholar will be searched. Two independent reviewers will screen titles and abstracts for studies that meet the review's inclusion criteria, and the full text of eligible studies will be reviewed. Data will be extracted from eligible studies using a structured data charting table developed by this team for inclusion by two independent reviewers and presented in a table and graphical form with a narrative summary.
Conflict of interest statement
The authors have declared that no competing interests exist
Similar articles
-
Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?Front Public Health. 2022 Jan 31;10:799984. doi: 10.3389/fpubh.2022.799984. eCollection 2022. Front Public Health. 2022. PMID: 35174123 Free PMC article. Review.
-
Implementation Strategies Used to Increase Human Papillomavirus Vaccination Uptake by Adolescent Girls in Sub-Saharan Africa: A Scoping Review.Vaccines (Basel). 2023 Jul 16;11(7):1246. doi: 10.3390/vaccines11071246. Vaccines (Basel). 2023. PMID: 37515061 Free PMC article.
-
Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.Trop Med Int Health. 2021 Nov;26(11):1345-1355. doi: 10.1111/tmi.13660. Epub 2021 Sep 1. Trop Med Int Health. 2021. PMID: 34310816 Review.
-
Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.BMC Public Health. 2023 May 26;23(1):974. doi: 10.1186/s12889-023-15842-1. BMC Public Health. 2023. PMID: 37237329 Free PMC article.
-
Exploring intersectional determinants of, and interventions for, low uptake of human papillomavirus vaccine in sub-Saharan Africa: a scoping review protocol.BMJ Open. 2025 Jan 8;15(1):e083848. doi: 10.1136/bmjopen-2023-083848. BMJ Open. 2025. PMID: 39779276 Free PMC article.
Cited by
-
Selecting and Tailoring Implementation Strategies to Improve Human Papillomavirus Vaccine Uptake in Zambia: A Nominal Group Technique Approach.Vaccines (Basel). 2024 May 15;12(5):542. doi: 10.3390/vaccines12050542. Vaccines (Basel). 2024. PMID: 38793793 Free PMC article.
-
Malignancy and viral infections in Sub-Saharan Africa: A review.Front Virol. 2023;3:1103737. doi: 10.3389/fviro.2023.1103737. Epub 2023 Mar 6. Front Virol. 2023. PMID: 37476029 Free PMC article.
-
"When you get the HPV vaccine, it will prevent cervical cancer; it will act as a shield": adolescent girls' knowledge and perceptions regarding the human papillomavirus vaccine in Zambia.Front Health Serv. 2023 Sep 13;3:1208458. doi: 10.3389/frhs.2023.1208458. eCollection 2023. Front Health Serv. 2023. PMID: 37780403 Free PMC article.
-
Factors associated with uptake of human papilloma virus vaccine among school girls aged 9-14 years in Lira City northern Uganda: a cross-sectional study.BMC Womens Health. 2023 Jul 8;23(1):362. doi: 10.1186/s12905-023-02511-z. BMC Womens Health. 2023. PMID: 37420225 Free PMC article.
-
Determinants of the Implementation of Human Papillomavirus Vaccination in Zambia: Application of the Consolidated Framework for Implementation Research.Vaccines (Basel). 2023 Dec 28;12(1):32. doi: 10.3390/vaccines12010032. Vaccines (Basel). 2023. PMID: 38250845 Free PMC article.
References
-
- Loke AY, Kwan ML, Wong YT, Wong AKY. The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review. J Prim Care Community Health. 2017;8(4):349–62. Epub 2017/11/23. doi: 10.1177/2150131917742299 ; PubMed Central PMCID: PMC5932744. - DOI - PMC - PubMed
-
- WHO. Weekly Epidemiological Report. Full article. 2009 2009. Report No.
-
- De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al.. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013;31 Suppl 5(0 5):F32–46. Epub 2013/12/18. doi: 10.1016/j.vaccine.2012.07.092 ; PubMed Central PMCID: PMC4144870. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials